YY-23

YY-23 is a selective inhibitor of NMDAR (containing GluN2C or GluN2D) . YY-23 inhibits GABAergic neurotransmission and enhances excitatory transmission by inhibiting NMDARs containing GluN2D on GABAergic interneurons in the prefrontal cortex. YY-23 has antidepressant activity and can be used for the research of neurological diseases[1].

Product Specifications

CAS Number

[1365029-75-9]

UNSPSC

12352005

Target

IGluR

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Purity

98.12

Smiles

CC1=C(O[C@H]2C[C@@]3([H])[C@]4([H])CC[C@@]5(C[C@H](CC[C@@]5([C@@]4([H])CC[C@@]3([C@]21[H])C)C)O)[H])CC[C@@H](CO[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C

Molecular Formula

C33H54O8

Molecular Weight

578.78

References & Citations

[1]Zhang J, et al. An antidepressant mechanism underlying the allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneurons. Sci Adv. 2025 Mar 7;11 (10) :eadq0444.